How I Got My 2nd Dose of AZ

It was about time for me to get my 2nd dose. We were told that we could register our appointments starting last week. My 1st dose was on 8/28, 2 weeks after the rest of my coworkers. For what reason, I don’t know. Probably because I’m younger.

Continue reading “How I Got My 2nd Dose of AZ”

Compound in Panda Blood Could Fight Superbugs


Researchers have discovered a potent antibody in panda blood, which could help fight increasingly prevalent drug-resistant strains of infections.

Read more @ SciTechDaily

3D Printing Using DNA Could Make Drugs

Credit: widdowquinn/Flickr)

New technology that combines the computer-aided design software inSequio with nanoscale fabrication technology could allow for the 3D printing of drugs using DNA.

Read more @ SciTechDaily

Synthesizing a Flu Vaccine Without the Virus


A new vaccine strategy, which uses synthetic messenger RNA (mRNA) instead of proteins purified from viruses, could make flu shots cheaper, safer, and easier to produce. German scientists have shown that they have been able to protect mice, ferrets, and pigs against influenza.

Read more @ SciTechDaily

Phase III Vaccine Trial in Africa Gives Poor Results about New Malaria Drug


A phase III clinical trial in Africa of the RTS,S/AS01 malaria vaccine has reported disappointing results. The vaccine failed to show substantial protection for infants who received their first shot between 6 and 12 weeks of age.

Read more @ SciTechDaily

Hepatitis E Vaccine Debuts Thanks to Chinese Biotech Partnership


The world’s first vaccine against the hepatitis E virus began being deployed from China last week, promising to stop the propagation of a disease that infects 20 million people yearly and claims 70,000 lives. This vaccine is the result of an unusual public-private partnership in China’s biotechnology sector, and could help deliver other vaccines for diseases that have been overlooked.

Read more @ SciTechDaily

HIV Vaccine Trial Identifies Target That Could Improve Effectiveness


A new vaccine trial has revealed a weak spot in HIV, which could lead to an effective vaccine against AIDS. The vaccine turns the immune system against the virus, and offers more protection from infections.

Read more @ SciTechDaily

%d bloggers like this: